I am a US Air Force Academy graduate and pilot. I have a Bachelors of Science in Economics. I flew KC-135 tankers and also worked as the budget officer in the comptroller’s squadron. I started off my civilian career as a stock broker for Dean Witter. After leaving Dean Witter I worked at a regional Broker Dealer called National Securities. I was a research analyst and authored and published reports in the aerospace sector. I am no stranger to public speaking and was a guest professor at the local community college teaching about the stock and options markets. In 1999 I left the securities business to test my skills as an entrepreneur.
Currently I work as a contract CFO for various public companies.
I am a hedge fund manager focused on healthcare stocks.
I started my career almost 20 years ago as an investment banker. After a stint in private equity, I ended up working as an analyst at a large and prominent hedge fund. I was
known by many in the industry for my indepth due diligence process. One of
my high profile short ideas was published in a book about the fund, as an
example of the high quality research they were able to do.
When I left to start my own fund, I had the privilege of receiving part of my
start-up capital from one of the legends of the hedge fund industry. Sitting next to him and walking him through my process step by step, stock after stock, is one of my most cherished professional memories.
5% of the incentive fees of my fund are committed to charity
I'm an Army veteran and former energy dividend writer for The Motley Fool. My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams, and enrich their lives. With 22 years of investing experience, I've learned what works and more importantly, what doesn't, when it comes to building long-term wealth and income streams. I'm currently on an epic quest to build a broadly diversified, high-quality, high-yield dividend growth portfolio that:
1. Pays 6% to 7% yield
2. Offers 5% to 6% annual dividend growth
3. Pays dividends AT LEAST on a weekly, but preferably, daily basis
Editor for The Biotech Forum & The Insiders Forum; two of the most subscribed to services available via SeekingAlpha's MarketPlace. Long time Real Money Pro contributor. Biotech investor for a quarter century and frequent speaker on the topic at investment conferences like the MoneyShow and in interviews. For FREE weekly investment reports on small, attractive biotech stocks just register at biotechfreereports.com. To get my articles and instablogs as soon as they are published, please hit my profile and become a real-time follower.
I'm a chartered accountant by profession, hailing from India, who is also pursuing CFA. I look for investments that generate strong value in the long run, and also help investors avoid pitfalls through my analysis.
MBBS, MD, MBA (NYU-Stern, Finance), worked/did research at Cornell and Harvard Affiliated Hospitals
Portfolio Manager/founder for own US biotech/pharma-focused asset management firm, Vasuda Capital Management (vasudacapitalmanagement.com).
Founder and Sponsor: Vasuda Global Orphan/Rare Diseases Index, first global equity index representing the orphan/rare disease sector (vasudaindices.com), index calculator=Solactive A.G.
Linkedin profile: https://www.linkedin.com/in/bhavneeshsharmamd/
I am an individual and occasional investor with a passion for biotechnology and stocks. I am working as an engineer with ties to the healthcare sector.
I build investment theses based on thorough personal research and end up picking only stocks that I think hold a very high and long-term potential. I specialize in micro-cap and/or European biotechs, tracking undervalued opportunities and basing my investment choices on the deep analysis of a company's fundamentals and its long-term perspective (at least several years).
Follow me on twitter: https://twitter.com/Logribel
I'm a young private investor. I prefer concentrated bets on small, quality businesses. I'm a strategic generalist, tactical specialist; I scan broadly looking for quirky things to become obsessed with for awhile, to accumulate clusters of competence in neglected niches. I'll place on my watch-list most anything that is predictable enough to value accurately, and wait for the right price. My idea horizons, which used to be ~1 year, seem to be lengthening.
My current top holdings are FN, KTCC, AGM, NVMI, EMAN, SILC, and SLP.
Arrow Loop Research delivers a value-based investing newsletter called Arrow Loop Research's Actionable Ideas for Maximizing Returns. Sign up for a free trial here. Arrow Loop Research provides general investment advice. Nothing contained in the newsletter should be construed as specific investment advice.
Dr. Paul Price, writer of Arrow Loop Research's premium research service, writes about stocks, options and the market every weekday on Real Money Pro, a subscription site on TheStreet.com. Paul has been a speaker at the International Traders Expo in New York City and the Options and Forex Expo in Las Vegas. He also gives investment seminars for subscribers of TheStreet's multiple subscription sites. Dr. Price is a featured contributor on Market Shadows.com, GuruFocus.com and TalkMarkets.com.
Paul followed his passion for the stock market when he gave up his career as a dentist to join Merrill Lynch back in April of 1987. Paul feels that he is “living the dream” of many investors. He stopped “going to work” when he turned 50 (in the year 2000) and has been living well from his investment returns ever since.
Paul enjoys sharing the accumulated market wisdom he’s gained from years in the markets. He loves analyzing companies and picking individual stocks. According to Paul, once you know what equities to buy, option writing (selling covered calls and/or naked puts) just flows naturally. They serve as ways to impose investment discipline and create income while providing an extra margin of safety versus plain vanilla share ownership. Paul’s articles stand out for their unique graphics which are packed with information which distills our TMI (too much information) world into easy to understand, and actionable advice.